Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Microscopy

Start-up Gandeeva Therapeutics to use cryo-EM to find new drugs

by Michael McCoy
February 4, 2022 | A version of this story appeared in Volume 100, Issue 5

Gandeeva Therapeutics has raised $40 million in series A funding to advance the use of cryo electron microscopy (cryo-EM) and machine learning to discover drugs. The firm was founded by Sriram Subramaniam, a University of British Columbia chemist who pioneered the use of cryo-EM to visualize drugs binding to targets. The investment was led by Lux Capital and Leaps by Bayer. The Bayer unit is also a recent investor in Cellino Biotech and Metagenomi.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.